These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 7784091)
1. Tyrosine phosphorylation of Shc proteins and formation of Shc/Grb2 complex correlate to the transformation of NIH3T3 cells mediated by the point-mutation activated neu. Xie Y; Li K; Hung MC Oncogene; 1995 Jun; 10(12):2409-13. PubMed ID: 7784091 [TBL] [Abstract][Full Text] [Related]
2. Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites. Soler C; Alvarez CV; Beguinot L; Carpenter G Oncogene; 1994 Aug; 9(8):2207-15. PubMed ID: 8036006 [TBL] [Abstract][Full Text] [Related]
3. Collagen-homology domain 1 deletion mutant of Shc suppresses transformation mediated by neu through a MAPK-independent pathway. Li K; Shao R; Hung MC Oncogene; 1999 Apr; 18(16):2617-26. PubMed ID: 10353605 [TBL] [Abstract][Full Text] [Related]
4. A new function for phospholipase C-gamma1: coupling to the adaptor protein GRB2. Pei Z; Maloney JA; Yang L; Williamson JR Arch Biochem Biophys; 1997 Sep; 345(1):103-10. PubMed ID: 9281317 [TBL] [Abstract][Full Text] [Related]
5. Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis. Saucier C; Papavasiliou V; Palazzo A; Naujokas MA; Kremer R; Park M Oncogene; 2002 Mar; 21(12):1800-11. PubMed ID: 11896612 [TBL] [Abstract][Full Text] [Related]
6. Gi-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc. Kranenburg O; Verlaan I; Hordijk PL; Moolenaar WH EMBO J; 1997 Jun; 16(11):3097-105. PubMed ID: 9214627 [TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of the SHC proteins on tyrosine correlates with the transformation of fibroblasts and erythroblasts by the v-sea tyrosine kinase. Crowe AJ; McGlade J; Pawson T; Hayman MJ Oncogene; 1994 Feb; 9(2):537-44. PubMed ID: 8290264 [TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor-receptor mutant lacking the autophosphorylation sites induces phosphorylation of Shc protein and Shc-Grb2/ASH association and retains mitogenic activity. Gotoh N; Tojo A; Muroya K; Hashimoto Y; Hattori S; Nakamura S; Takenawa T; Yazaki Y; Shibuya M Proc Natl Acad Sci U S A; 1994 Jan; 91(1):167-71. PubMed ID: 7506413 [TBL] [Abstract][Full Text] [Related]
9. An alternative to phosphotyrosine-containing motifs for binding to an SH2 domain. Rojas M; Yao S; Donahue JP; Lin YZ Biochem Biophys Res Commun; 1997 May; 234(3):675-80. PubMed ID: 9175774 [TBL] [Abstract][Full Text] [Related]
10. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Seetharam L; Gotoh N; Maru Y; Neufeld G; Yamaguchi S; Shibuya M Oncogene; 1995 Jan; 10(1):135-47. PubMed ID: 7824266 [TBL] [Abstract][Full Text] [Related]
11. N-Shc: a neural-specific adapter molecule that mediates signaling from neurotrophin/Trk to Ras/MAPK pathway. Nakamura T; Sanokawa R; Sasaki Y; Ayusawa D; Oishi M; Mori N Oncogene; 1996 Sep; 13(6):1111-21. PubMed ID: 8808684 [TBL] [Abstract][Full Text] [Related]
12. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Salcini AE; McGlade J; Pelicci G; Nicoletti I; Pawson T; Pelicci PG Oncogene; 1994 Oct; 9(10):2827-36. PubMed ID: 8084588 [TBL] [Abstract][Full Text] [Related]
13. Constitutive phosphorylation of Shc proteins in human tumors. Pelicci G; Lanfrancone L; Salcini AE; Romano A; Mele S; Grazia Borrello M; Segatto O; Di Fiore PP; Pelicci PG Oncogene; 1995 Sep; 11(5):899-907. PubMed ID: 7675449 [TBL] [Abstract][Full Text] [Related]
14. Actinomycin D as a novel SH2 domain ligand inhibits Shc/Grb2 interaction in B104-1-1 (neu*-transformed NIH3T3) and SAA (hEGFR-overexpressed NIH3T3) cells. Kim HK; Nam JY; Han MY; Lee EK; Choi JD; Bok SH; Kwon BM FEBS Lett; 1999 Jun; 453(1-2):174-8. PubMed ID: 10403397 [TBL] [Abstract][Full Text] [Related]
15. Dominant-negative mutants of Grb2 induced reversal of the transformed phenotypes caused by the point mutation-activated rat HER-2/Neu. Xie Y; Pendergast AM; Hung MC J Biol Chem; 1995 Dec; 270(51):30717-24. PubMed ID: 8530511 [TBL] [Abstract][Full Text] [Related]